Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment-Reference-Cited by-同舟云学术

Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment

Published:2017-07-13 Issue:3 Volume:59 Page:733-738
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Chelysheva Ekaterina¹,Turkina Anna¹,Polushkina Evgenia²,Shmakov Roman²,Zeifman Alexey³,Aleshin Sergey⁴,Shokhin Igor⁴,Guranda Dorel⁵,Oksenjuk Oksana⁶,Mordanov Sergey⁶,Kazakbaeva Khamida⁷,Chilov Ghermes³

Affiliation:

1. FSBI National Research Center for Hematology of the Healthcare Ministry of the Russian Federation, Moscow, Russia;

2. FSBI Scientific Center of Obstetrics, Gynecology and Perinatology of the Healthcare Ministry named after V.I. Kulakov, Moscow, Russia;

3. FSBI N.D. Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences, Moscow, Russia;

4. Center of Pharmaceutical Analytics Ltd, Moscow, Russia;

5. Farm Innovation Technologies Ltd, Moscow, Russia;

6. FBEI HPE Rostov State Medical University of the Healthcare Ministry of the Russian Federation, Rostov, Russia;

7. Research Institute of Hematology and Blood Transfusion MOH of Uzbekistan, Tashkent, Uzbekistan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1347929

Reference39 articles.

1. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

2. Philadelphia ChromosomePositive Leukemias: From Basic Mechanisms to Molecular Therapeutics

3. The development of imatinib as a therapeutic agent for chronic myeloid leukemia

4. BCR-ABL in Chronic Myelogenous Leukemia – How Does It Work?

5. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful Prediction of Fetal Exposure to Dual BCRP/P‐gp Drug Substrates Using the Efflux Ratio‐Relative Expression Factor Approach and PBPK M&S;Clinical Pharmacology & Therapeutics;2024-01-08

2. Physiologically Based Pharmacokinetic Modeling of Nilotinib for Drug‐Drug Interactions, Pediatric Patients, and Pregnancy and Lactation;The Journal of Clinical Pharmacology;2023-11-22

3. Pregnancy and long-term outcomes of female patients with chronic myeloid leukemia on tyrosine kinase inhibitors who experienced unplanned pregnancies;Leukemia Research;2023-10

4. Patient-Centered Care in the Management of Cancer During Pregnancy;American Society of Clinical Oncology Educational Book;2023-05

5. Managing women of childbearing age with chronic myeloid leukemia: safety and treatment considerations;Expert Review of Hematology;2023-04-20